To advance treatment for post traumatic stress disorder, biotechnology firm raises $2.2M
Mood and behavior disorders, such as post traumatic stress and depression, affect up to 40 million in the U.S. A biotechnology company developing a way to treat the disorders has raised $2.2 million, according to a Form D filing with the U.S. Securities and Exchange Commission. The financing will help Azevan Pharmaceuticals advance its two […]